Orthocell Limited (OCC) 2021年年度报告「ASX」.pdf

1、Appendix 4E Preliminary final Report +See chapter 19 for defined terms 30/06/2016 Appendix 4E Page 1 Rules 4.3A Appendix 4E Preliminary final report Name of entity ORTHOCELL LIMITED ABN or equivalent company reference Financial year ended(current period)57 118 897 135 30 June 2021 For announcement t

2、o the market Current year reported amount$Change up/(down)from previous year%Revenues from product sales 1,017,962 up 41.5%Other revenues from continuing operations 273,873 up 19.3%Total revenues from continuing operations 1,255,835 up 36.7%Loss from ordinary activities after tax attributable to mem

3、bers 9,037,025 up 46.9%Net loss for the period attributable to members 9,037,025 up 46.9%Dividends(distributions)Amount per security Franked amount per security Interim dividend Nil-Final dividend Nil-Previous corresponding period Nil-+Record date for determining entitlements to the dividend,(in the

4、 case of a trust,distribution)N/A Net Tangible Assets per share 30 June 2021 30 June 2020 Net tangible asset backing per ordinary security (cents per share)8.16 10.44 The above results should be read in conjunction with the notes and commentary contained in this report.Appendix 4E Preliminary final

5、Report +See chapter 19 for defined terms 30/06/2016 Appendix 4E Page 2 Compliance statement 1 This report has been prepared in accordance with AASB Standards,other AASB authoritative pronouncements and Urgent Issues Group Consensus Views or other standards acceptable to ASX.2 This report,and the+acc

6、ounts upon which the report is based(if separate),use the same accounting policies.3 This report does give a true and fair view of the matters disclosed.4 This report is based on+accounts to which one of the following applies.(Tick one)The+accounts have been audited.The+accounts have been subject to